Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03307161 · ClinicalTrials.gov registry record · NA

Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia

A NA study of Parkinson Disease and Dystonia, sponsored by New York Institute of Technology.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03307161 is a NA study of Parkinson Disease and Dystonia that has completed, run by New York Institute of Technology. The registered enrollment target is 10 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03307161, a NA study of Parkinson Disease and Dystonia, has completed, sponsored by New York Institute of Technology.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This study will determine if posture and heart rate variability will significantly improve in Parkinsons disease with camptocormia after osteopathic manual treatments dystonia.

Interventions

  • OTHER osteopathic manual therapy

Study Locations (1)

New York

  • New York Institute of Technology - Old Westbury

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2016-11
Est. Completion 2021-09-20
Phase NA

Sponsor

New York Institute of Technology

49 total trials

What the Registry Record Tells You About NCT03307161

The ClinicalTrials.gov registry entry for NCT03307161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which osteopathic manual therapy is the first listed.

NCT03307161 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03307161 about?

NCT03307161 is a clinical study titled "Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia". This study will determine if posture and heart rate variability will significantly improve in Parkinsons disease with camptocormia after osteopathic manual treatments dystonia.

What is the current status of trial NCT03307161?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-11. Estimated completion is 2021-09-20.

What conditions does trial NCT03307161 study?

This clinical trial studies the following conditions: Parkinson Disease, Dystonia, Autonomic Dysreflexia.

What interventions are being tested in trial NCT03307161?

The interventions under investigation include: osteopathic manual therapy (OTHER).

Who is sponsoring clinical trial NCT03307161?

This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03307161 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.